Bryan T. Kelly, MD, MBA President and Chief Executive Officer | Hospital for Special Surgery
Bryan T. Kelly, MD, MBA President and Chief Executive Officer | Hospital for Special Surgery
Dr. Martin W. Roche, a knee surgeon and director of arthroplasty at HSS Florida, has shared insights on the use of GLP1 weight loss drugs in knee replacement surgery with WPB25. Dr. Roche recommends these medications for many patients, noting their potential benefits.
"We have definitely seen patients that have been able to delay surgery," said Dr. Roche. He explained that reducing stress on joints can lead to less pain for patients.
Dr. Roche also highlighted the positive impact on diabetic patients who previously were not healthy enough for knee or hip surgeries but became eligible after using the weight loss drugs.
The full interview is available at wpbf.com.
Alerts Sign-up